Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Anne Fuhlbrigge

Concepts (429)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
98
2025
1767
9.800
 Why?
Anti-Asthmatic Agents
28
2025
251
3.360
 Why?
Adrenal Cortex Hormones
28
2025
478
3.310
 Why?
Forced Expiratory Volume
19
2019
448
1.540
 Why?
Pulmonary Disease, Chronic Obstructive
11
2022
919
1.370
 Why?
Severity of Illness Index
20
2020
2917
0.950
 Why?
Administration, Inhalation
25
2025
574
0.940
 Why?
Anti-Inflammatory Agents
10
2016
474
0.850
 Why?
Albuterol
5
2015
73
0.830
 Why?
Bronchodilator Agents
12
2016
182
0.820
 Why?
Lung Transplantation
10
2017
338
0.790
 Why?
Budesonide
14
2016
49
0.790
 Why?
Remote Consultation
4
2025
66
0.730
 Why?
Nedocromil
11
2016
20
0.700
 Why?
Humans
129
2025
144261
0.680
 Why?
Nasal Polyps
1
2021
59
0.680
 Why?
Self Report
3
2023
863
0.670
 Why?
Endpoint Determination
2
2020
83
0.660
 Why?
Pharmacogenetics
2
2015
172
0.660
 Why?
Food Hypersensitivity
1
2022
164
0.630
 Why?
Sinusitis
1
2021
228
0.580
 Why?
Virus Diseases
1
2021
216
0.570
 Why?
Glucocorticoids
4
2022
533
0.560
 Why?
Lung
7
2019
4108
0.560
 Why?
Physicians
2
2021
938
0.560
 Why?
Symptom Assessment
1
2019
137
0.540
 Why?
Hospitalization
13
2020
2424
0.530
 Why?
Sleep Apnea, Obstructive
1
2021
299
0.510
 Why?
Androstadienes
3
2012
76
0.500
 Why?
Bone Density
2
2014
482
0.490
 Why?
Child
53
2022
22537
0.490
 Why?
Disease Progression
14
2020
2840
0.480
 Why?
Oxygen Inhalation Therapy
4
2020
182
0.480
 Why?
Managed Care Programs
8
2008
136
0.480
 Why?
Male
82
2025
72035
0.460
 Why?
Precision Medicine
1
2020
456
0.460
 Why?
Emergency Service, Hospital
9
2013
2301
0.460
 Why?
Adult
47
2025
40262
0.450
 Why?
Adrenergic beta-2 Receptor Agonists
4
2020
26
0.440
 Why?
Cost Savings
1
2015
86
0.430
 Why?
Female
81
2025
77976
0.430
 Why?
Practice Patterns, Physicians'
7
2020
1347
0.420
 Why?
Patient Reported Outcome Measures
1
2018
487
0.420
 Why?
Peak Expiratory Flow Rate
2
2011
25
0.400
 Why?
Cost-Benefit Analysis
7
2022
623
0.390
 Why?
Middle Aged
40
2025
35762
0.380
 Why?
Phenotype
6
2025
3157
0.380
 Why?
Comorbidity
4
2021
1646
0.350
 Why?
Academic Medical Centers
3
2024
545
0.340
 Why?
Surveys and Questionnaires
14
2022
6021
0.330
 Why?
Adolescent
37
2019
22281
0.330
 Why?
Medical Records Systems, Computerized
3
2008
95
0.330
 Why?
Administration, Oral
6
2021
847
0.320
 Why?
Mentors
1
2012
218
0.320
 Why?
Quality of Life
12
2023
3166
0.320
 Why?
Respiratory Function Tests
10
2015
546
0.310
 Why?
United States
23
2022
15876
0.310
 Why?
Interprofessional Relations
3
2021
280
0.300
 Why?
Faculty, Medical
1
2012
301
0.300
 Why?
Spirometry
8
2020
230
0.300
 Why?
Child, Preschool
31
2016
11774
0.300
 Why?
Treatment Outcome
16
2025
11643
0.290
 Why?
Child Development
1
2014
484
0.290
 Why?
Group Practice
1
2008
6
0.280
 Why?
Anti-Allergic Agents
2
2008
40
0.280
 Why?
Oxygen
3
2018
995
0.270
 Why?
Computer Simulation
1
2012
1025
0.270
 Why?
Aged
22
2022
25850
0.260
 Why?
Dyspnea
3
2022
251
0.260
 Why?
Drug Utilization
4
2005
166
0.250
 Why?
Randomized Controlled Trials as Topic
8
2020
1705
0.240
 Why?
Primary Health Care
5
2025
1710
0.240
 Why?
Primary Graft Dysfunction
2
2017
35
0.240
 Why?
Quality Assurance, Health Care
1
2008
336
0.240
 Why?
Follow-Up Studies
17
2017
5389
0.230
 Why?
Respiratory Sounds
1
2006
105
0.230
 Why?
Bronchiolitis Obliterans
3
2017
66
0.230
 Why?
Gift Giving
1
2005
9
0.230
 Why?
Diagnostic Techniques, Respiratory System
1
2005
5
0.230
 Why?
Allergists
2
2022
13
0.230
 Why?
Genetic Testing
1
2008
478
0.220
 Why?
Delivery of Health Care
2
2021
940
0.220
 Why?
Medication Adherence
2
2023
512
0.210
 Why?
Cohort Studies
14
2013
5935
0.210
 Why?
Specialization
2
2025
134
0.210
 Why?
Retrospective Studies
18
2024
17009
0.210
 Why?
Natural Language Processing
1
2025
103
0.200
 Why?
Massachusetts
5
2016
177
0.200
 Why?
Time Factors
10
2020
7155
0.200
 Why?
Leadership
2
2022
408
0.200
 Why?
Antibodies, Monoclonal
2
2008
1519
0.200
 Why?
Medicine
1
2025
125
0.200
 Why?
Genetic Variation
1
2008
982
0.190
 Why?
Rhinitis, Allergic, Perennial
1
2003
20
0.190
 Why?
Steroids
8
2011
160
0.190
 Why?
Recurrence
5
2013
1134
0.190
 Why?
Genetic Predisposition to Disease
2
2025
2359
0.190
 Why?
Health Status
1
2008
833
0.190
 Why?
Predictive Value of Tests
9
2012
2111
0.180
 Why?
Beclomethasone
1
2022
8
0.180
 Why?
Young Adult
11
2019
13990
0.180
 Why?
Multicenter Studies as Topic
4
2018
402
0.180
 Why?
Prevalence
4
2022
2815
0.180
 Why?
Models, Theoretical
4
2007
582
0.180
 Why?
Tiotropium Bromide
2
2018
5
0.170
 Why?
Desensitization, Immunologic
1
2022
89
0.170
 Why?
Nebulizers and Vaporizers
2
2020
62
0.170
 Why?
Biomarkers
3
2021
4254
0.170
 Why?
Social Class
2
2022
268
0.170
 Why?
Patient Preference
1
2023
221
0.160
 Why?
Churg-Strauss Syndrome
1
2020
27
0.160
 Why?
Bronchoconstriction
3
2011
29
0.160
 Why?
Pulmonologists
1
2020
14
0.160
 Why?
Capacity Building
1
2021
58
0.160
 Why?
Granulomatosis with Polyangiitis
1
2020
46
0.160
 Why?
Muscarinic Antagonists
1
2020
30
0.160
 Why?
Agammaglobulinemia
1
2020
36
0.160
 Why?
Physician-Patient Relations
2
2021
581
0.150
 Why?
Electronic Health Records
2
2025
1169
0.150
 Why?
Practice Guidelines as Topic
5
2020
1559
0.150
 Why?
Risk Factors
12
2018
10699
0.150
 Why?
Air Pollution, Indoor
2
2002
181
0.150
 Why?
Treatment Adherence and Compliance
1
2019
27
0.150
 Why?
Exercise Test
1
2022
634
0.140
 Why?
Receptors, IgE
2
2009
43
0.140
 Why?
Allergens
1
2021
384
0.140
 Why?
Prognosis
8
2017
4278
0.140
 Why?
Vitamin D
2
2012
399
0.130
 Why?
Fossil Fuels
1
1997
10
0.130
 Why?
Hypersensitivity
1
2020
252
0.130
 Why?
Alemtuzumab
1
2017
15
0.130
 Why?
Photopheresis
1
2017
9
0.130
 Why?
Drug Prescriptions
2
2011
280
0.130
 Why?
Biological Products
1
2020
251
0.130
 Why?
Respiration
1
2017
206
0.130
 Why?
Physicians, Primary Care
3
2021
206
0.130
 Why?
Respiration Disorders
1
1997
77
0.130
 Why?
Emergency Medical Services
2
2007
696
0.120
 Why?
Statistics, Nonparametric
1
2017
427
0.120
 Why?
Drug Therapy, Combination
5
2020
1044
0.120
 Why?
Drug Combinations
3
2012
390
0.120
 Why?
Drug Monitoring
1
2020
389
0.120
 Why?
Immunomodulation
1
2017
101
0.120
 Why?
Socioeconomic Factors
4
2022
1312
0.120
 Why?
Tobacco Smoke Pollution
2
2010
233
0.120
 Why?
Scopolamine Derivatives
1
2015
3
0.120
 Why?
Breath Tests
2
2008
79
0.120
 Why?
Aged, 80 and over
6
2019
8243
0.120
 Why?
Embolism, Fat
1
2015
11
0.120
 Why?
Immunoglobulin G
1
2020
893
0.120
 Why?
Patient Admission
1
2018
218
0.120
 Why?
Cholinergic Antagonists
1
2015
23
0.120
 Why?
Transplants
1
2015
39
0.110
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2015
103
0.110
 Why?
Fluticasone-Salmeterol Drug Combination
2
2012
7
0.110
 Why?
Carcinoma, Bronchogenic
1
2015
20
0.110
 Why?
Genomics
2
2018
833
0.110
 Why?
Longitudinal Studies
6
2017
2926
0.110
 Why?
Referral and Consultation
1
2021
847
0.110
 Why?
Graft Rejection
2
2013
540
0.110
 Why?
Respiratory Tract Infections
2
2012
396
0.100
 Why?
Overweight
2
2011
606
0.100
 Why?
Ambulatory Care Information Systems
2
2005
5
0.100
 Why?
Prednisolone
1
2014
66
0.100
 Why?
Postoperative Complications
2
2017
2916
0.100
 Why?
Telemedicine
1
2023
940
0.100
 Why?
Risk
4
2015
909
0.100
 Why?
Education, Medical, Continuing
2
2005
131
0.100
 Why?
Guideline Adherence
3
2020
586
0.100
 Why?
Environmental Exposure
3
2006
587
0.100
 Why?
Airway Obstruction
1
2015
162
0.100
 Why?
Bronchial Hyperreactivity
3
2010
96
0.100
 Why?
Forecasting
1
2015
388
0.100
 Why?
Transplantation
1
2013
33
0.100
 Why?
Office Visits
4
2011
90
0.100
 Why?
Quality Improvement
1
2022
1285
0.100
 Why?
Insurance Claim Review
1
2013
82
0.100
 Why?
Peer Group
2
2012
242
0.090
 Why?
Growth
1
2012
49
0.090
 Why?
Medicare
2
2022
881
0.090
 Why?
Double-Blind Method
5
2010
2025
0.090
 Why?
Costs and Cost Analysis
1
2013
218
0.090
 Why?
Research
1
2015
428
0.090
 Why?
Methacholine Chloride
3
2008
50
0.090
 Why?
Metered Dose Inhalers
1
2012
8
0.090
 Why?
Cytomegalovirus Infections
2
2012
206
0.090
 Why?
Cost of Illness
3
2003
319
0.090
 Why?
Drug Dosage Calculations
1
2011
27
0.090
 Why?
Feedback
1
2012
181
0.090
 Why?
Logistic Models
5
2017
2104
0.090
 Why?
Mycoses
1
2012
88
0.090
 Why?
Antibodies, Monoclonal, Humanized
2
2008
985
0.090
 Why?
Antifungal Agents
1
2012
149
0.090
 Why?
Effect Modifier, Epidemiologic
1
2011
8
0.090
 Why?
Multivariate Analysis
7
2017
1533
0.090
 Why?
Professional Role
1
2012
158
0.090
 Why?
Body Height
1
2012
202
0.090
 Why?
Medication Errors
1
2012
83
0.080
 Why?
Morbidity
2
2022
323
0.080
 Why?
Epidemiologic Studies
1
2011
68
0.080
 Why?
Pneumococcal Vaccines
1
2012
130
0.080
 Why?
Mycobacterium
1
2012
116
0.080
 Why?
Obesity
3
2015
3057
0.080
 Why?
Diagnostic Errors
1
2012
175
0.080
 Why?
Patient Readmission
1
2016
756
0.080
 Why?
Program Development
1
2012
369
0.080
 Why?
Secondary Prevention
1
2012
253
0.080
 Why?
Drug Resistance
1
2011
153
0.080
 Why?
Vitamin D Deficiency
1
2012
185
0.080
 Why?
Probability
1
2011
308
0.080
 Why?
Chi-Square Distribution
2
2017
527
0.080
 Why?
Lung Diseases
1
2017
787
0.080
 Why?
Bronchial Provocation Tests
2
2008
47
0.080
 Why?
Fluticasone
2
2008
53
0.080
 Why?
Pragmatic Clinical Trials as Topic
2
2020
132
0.080
 Why?
Decision Support Techniques
2
2012
454
0.080
 Why?
Incidence
5
2020
2870
0.080
 Why?
Immunoglobulin E
2
2008
315
0.080
 Why?
Vital Capacity
4
2017
290
0.080
 Why?
Receptors, Corticotropin-Releasing Hormone
1
2009
28
0.080
 Why?
Lectins, C-Type
1
2009
62
0.080
 Why?
Ambulatory Care
2
2011
597
0.070
 Why?
Algorithms
1
2017
1834
0.070
 Why?
Smoking
3
2017
1468
0.070
 Why?
Health Services
2
2007
114
0.070
 Why?
Medication Therapy Management
1
2010
73
0.070
 Why?
Proportional Hazards Models
1
2012
1322
0.070
 Why?
Surgical Wound Infection
1
2012
316
0.070
 Why?
Odds Ratio
4
2017
1072
0.070
 Why?
Health Knowledge, Attitudes, Practice
2
2012
1409
0.070
 Why?
Pandemics
3
2022
1682
0.070
 Why?
Acute Disease
1
2011
1028
0.070
 Why?
Kaplan-Meier Estimate
3
2016
964
0.070
 Why?
Vitamin K Epoxide Reductases
1
2008
11
0.070
 Why?
Cytochrome P-450 CYP2C9
1
2008
19
0.070
 Why?
Cross-Sectional Studies
6
2010
5813
0.070
 Why?
Eosinophil Cationic Protein
1
2008
9
0.070
 Why?
Mixed Function Oxygenases
1
2008
49
0.070
 Why?
Adrenergic beta-Agonists
1
2008
91
0.070
 Why?
Aryl Hydrocarbon Hydroxylases
1
2008
45
0.070
 Why?
Program Evaluation
1
2012
946
0.070
 Why?
Genetic Techniques
1
2008
67
0.070
 Why?
Quality-Adjusted Life Years
2
2006
117
0.070
 Why?
Insurance, Pharmaceutical Services
1
2008
23
0.070
 Why?
Markov Chains
2
2006
126
0.070
 Why?
State Health Plans
1
2008
28
0.070
 Why?
Cost Sharing
1
2008
20
0.070
 Why?
Smoking Cessation
1
2012
439
0.070
 Why?
Trastuzumab
1
2008
118
0.070
 Why?
Reimbursement Mechanisms
1
2008
79
0.070
 Why?
Antibodies, Anti-Idiotypic
1
2007
51
0.070
 Why?
Chronic Disease
3
2017
1812
0.070
 Why?
Omalizumab
1
2007
43
0.070
 Why?
Mycobacterium Infections, Nontuberculous
1
2012
366
0.060
 Why?
Exercise Tolerance
2
2022
283
0.060
 Why?
Factor Analysis, Statistical
1
2008
292
0.060
 Why?
Health Surveys
2
2006
510
0.060
 Why?
Warfarin
1
2008
170
0.060
 Why?
Influenza Vaccines
1
2012
529
0.060
 Why?
Interviews as Topic
1
2011
898
0.060
 Why?
Antiviral Agents
1
2012
767
0.060
 Why?
Animals, Domestic
1
2006
17
0.060
 Why?
Databases, Factual
1
2012
1484
0.060
 Why?
Tomography, X-Ray Computed
1
2017
2730
0.060
 Why?
Lung Diseases, Interstitial
1
2013
659
0.060
 Why?
Health Services Accessibility
2
2021
1091
0.060
 Why?
Animals
2
2025
38030
0.060
 Why?
Physicians, Family
2
2004
173
0.060
 Why?
Eosinophils
1
2008
316
0.060
 Why?
Biomedical Research
1
2012
709
0.060
 Why?
Health Benefit Plans, Employee
1
2005
25
0.060
 Why?
Database Management Systems
1
2005
50
0.060
 Why?
Hip Fractures
1
2006
84
0.050
 Why?
Health Policy
1
2008
398
0.050
 Why?
Models, Biological
1
2012
1820
0.050
 Why?
Patients
1
2006
178
0.050
 Why?
Insurance Coverage
1
2006
238
0.050
 Why?
Utilization Review
1
2004
39
0.050
 Why?
Infant
3
2008
10022
0.050
 Why?
Body Mass Index
3
2015
2420
0.050
 Why?
Patient Education as Topic
3
2005
777
0.050
 Why?
Gene Expression Profiling
1
2011
1782
0.050
 Why?
Medicaid
1
2008
461
0.050
 Why?
Clinical Competence
1
2012
1241
0.050
 Why?
Prenatal Exposure Delayed Effects
1
2010
674
0.050
 Why?
Mass Screening
1
2012
1332
0.050
 Why?
Nitric Oxide
1
2008
897
0.050
 Why?
Vaccination
1
2012
1422
0.050
 Why?
Attitude to Health
1
2006
434
0.050
 Why?
Sex Factors
3
2016
2096
0.050
 Why?
Anticoagulants
1
2008
721
0.050
 Why?
Case Management
1
2003
66
0.050
 Why?
Clinical Trials as Topic
2
2005
1050
0.050
 Why?
Puerto Rico
1
2022
58
0.050
 Why?
Parents
3
2006
1401
0.050
 Why?
Choice Behavior
1
2004
177
0.050
 Why?
Anti-Bacterial Agents
2
2004
1906
0.050
 Why?
Symptom Flare Up
1
2022
37
0.050
 Why?
Sputum
1
2004
308
0.040
 Why?
Academies and Institutes
1
2022
60
0.040
 Why?
Circadian Rhythm
1
2006
513
0.040
 Why?
Health Services Research
1
2004
394
0.040
 Why?
Lung Neoplasms
1
2015
2637
0.040
 Why?
Minority Groups
1
2003
277
0.040
 Why?
Survival Rate
2
2016
2088
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2020
77
0.040
 Why?
Electronics
1
2021
70
0.040
 Why?
Clinical Trials, Phase III as Topic
1
2020
117
0.040
 Why?
Sample Size
1
2020
123
0.040
 Why?
Efficiency
1
2021
103
0.040
 Why?
Health Care Reform
1
2021
109
0.040
 Why?
Schools, Medical
1
2021
156
0.040
 Why?
Risk Assessment
3
2020
3637
0.040
 Why?
Patient Compliance
2
2016
585
0.040
 Why?
Patient Selection
2
2020
719
0.040
 Why?
Language
1
2022
321
0.040
 Why?
Stress, Psychological
1
2007
1147
0.040
 Why?
Time
1
2019
86
0.040
 Why?
Cluster Analysis
2
2014
519
0.040
 Why?
Health Education
1
2002
357
0.040
 Why?
Quality of Health Care
1
2003
688
0.030
 Why?
Poland
1
2017
34
0.030
 Why?
Bronchitis, Chronic
1
2017
16
0.030
 Why?
Republic of Korea
1
2017
41
0.030
 Why?
Cooperative Behavior
1
2021
462
0.030
 Why?
Patient-Centered Care
1
2003
540
0.030
 Why?
Sensitivity and Specificity
3
2013
1983
0.030
 Why?
Nitrogen Dioxide
1
1997
47
0.030
 Why?
Geography
1
2018
203
0.030
 Why?
Aftercare
1
2019
220
0.030
 Why?
Monitoring, Physiologic
2
2012
289
0.030
 Why?
Self Concept
1
2019
252
0.030
 Why?
Long-Term Care
1
2018
117
0.030
 Why?
Netherlands
1
2016
82
0.030
 Why?
Antineoplastic Agents
1
2008
2192
0.030
 Why?
Pediatrics
1
2005
1112
0.030
 Why?
Tuberculosis, Pulmonary
1
2017
131
0.030
 Why?
Forced Expiratory Flow Rates
1
2015
10
0.030
 Why?
Formoterol Fumarate
1
2015
6
0.030
 Why?
Salmeterol Xinafoate
1
2015
20
0.030
 Why?
Ethanolamines
1
2015
14
0.030
 Why?
Perception
1
2019
377
0.030
 Why?
Receptors, Adrenergic, beta-2
1
2015
35
0.030
 Why?
Treatment Failure
1
2016
363
0.030
 Why?
Dose-Response Relationship, Drug
2
2011
2026
0.030
 Why?
Feasibility Studies
1
2020
1087
0.030
 Why?
Education
1
2015
104
0.030
 Why?
Self Efficacy
1
2019
411
0.030
 Why?
Postoperative Period
1
2016
353
0.030
 Why?
Polymorphism, Single Nucleotide
2
2016
2143
0.030
 Why?
Immunosuppressive Agents
2
2015
846
0.030
 Why?
Age Factors
3
2008
3313
0.030
 Why?
Fatal Outcome
1
2015
307
0.030
 Why?
Biopsy
2
2013
1075
0.030
 Why?
Pilot Projects
1
2020
1867
0.030
 Why?
Combined Modality Therapy
1
2017
1264
0.030
 Why?
Patient Acceptance of Health Care
1
2021
878
0.030
 Why?
Gene Expression
1
2018
1487
0.020
 Why?
Telephone
2
2005
174
0.020
 Why?
Echinocandins
1
2012
8
0.020
 Why?
Lipopeptides
1
2012
16
0.020
 Why?
Aspergillosis
1
2012
23
0.020
 Why?
Amphotericin B
1
2012
37
0.020
 Why?
Intention to Treat Analysis
1
2012
79
0.020
 Why?
Candidiasis
1
2012
64
0.020
 Why?
Tissue Donors
1
2015
424
0.020
 Why?
Transplantation, Homologous
1
2013
415
0.020
 Why?
Mycobacterium avium Complex
1
2012
88
0.020
 Why?
Age Distribution
2
2003
397
0.020
 Why?
Cromolyn Sodium
2
2001
6
0.020
 Why?
Hypoxia
1
2019
1199
0.020
 Why?
Leukotriene Antagonists
1
2011
23
0.020
 Why?
Extracorporeal Membrane Oxygenation
1
2015
382
0.020
 Why?
Triazoles
1
2012
184
0.020
 Why?
Self Care
2
2005
388
0.020
 Why?
Functional Residual Capacity
1
2010
7
0.020
 Why?
Reference Values
1
2012
797
0.020
 Why?
Colorado
1
2021
4562
0.020
 Why?
Costa Rica
1
2010
18
0.020
 Why?
Principal Component Analysis
1
2011
197
0.020
 Why?
Nontuberculous Mycobacteria
1
2012
208
0.020
 Why?
Health
1
2010
81
0.020
 Why?
Inhalation
1
2010
29
0.020
 Why?
Genome-Wide Association Study
1
2016
1406
0.020
 Why?
Environment
1
2011
305
0.020
 Why?
Observation
1
2008
54
0.020
 Why?
Sex Ratio
1
2008
16
0.020
 Why?
Least-Squares Analysis
1
2008
76
0.020
 Why?
Models, Econometric
1
2008
34
0.020
 Why?
Prospective Studies
2
2012
7970
0.020
 Why?
Health Services Administration
1
2007
8
0.020
 Why?
Treatment Refusal
1
2008
98
0.020
 Why?
Intelligence
1
2007
112
0.020
 Why?
Social Isolation
1
2007
72
0.020
 Why?
Puberty
1
2008
140
0.020
 Why?
Body Weight
1
2011
976
0.020
 Why?
Child Behavior Disorders
1
2007
118
0.020
 Why?
Exercise
1
2016
2193
0.010
 Why?
Insurance, Health
1
2007
301
0.010
 Why?
CD4-Positive T-Lymphocytes
1
2011
1128
0.010
 Why?
Genotype
1
2009
1833
0.010
 Why?
Bronchoconstrictor Agents
1
2003
14
0.010
 Why?
Organizational Innovation
1
2004
120
0.010
 Why?
Health Status Indicators
1
2004
165
0.010
 Why?
Case-Control Studies
1
2010
3592
0.010
 Why?
Systems Integration
1
2003
36
0.010
 Why?
Computer Systems
1
2003
56
0.010
 Why?
Motor Activity
1
2007
720
0.010
 Why?
Histamine H1 Antagonists
1
2002
24
0.010
 Why?
Drug Administration Schedule
1
2004
778
0.010
 Why?
Self Disclosure
1
2002
62
0.010
 Why?
Child Welfare
1
2004
231
0.010
 Why?
Administration, Intranasal
1
2002
93
0.010
 Why?
Confidence Intervals
1
2002
333
0.010
 Why?
Regression Analysis
1
2003
998
0.010
 Why?
Nurse's Role
1
2003
170
0.010
 Why?
Point-of-Care Systems
1
2003
187
0.010
 Why?
Health Care Surveys
1
2002
538
0.010
 Why?
Sex Distribution
1
2001
380
0.010
 Why?
Patient Satisfaction
1
2004
704
0.010
 Why?
Linear Models
1
2002
850
0.010
 Why?
Disease Management
1
2003
643
0.010
 Why?
Decision Support Systems, Clinical
1
2003
265
0.010
 Why?
Bronchoscopy
1
2000
227
0.010
 Why?
Caregivers
1
2007
1047
0.010
 Why?
Internet
1
2003
698
0.010
 Why?
Pregnancy
1
2010
7180
0.010
 Why?
Survival Analysis
1
2000
1382
0.010
 Why?
Infant, Newborn
1
2004
6424
0.010
 Why?
Fuhlbrigge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (429) concept(s)
_
Co-Authors Expand Description
See all (16) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)